O=C1C[C@@H](Sc2ccccc2)C2(OCCO2)[C@H]2ON3CCC[C@@H]3[C@@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?